NCT06719362 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT06719362
Title	A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Providence Health & Services
Indications	gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma esophagus adenocarcinoma gastric adenocarcinoma Advanced Solid Tumor glioblastoma
Therapies	M3T01 M3T01 + Temozolomide M3T01 + Pembrolizumab Fluorouracil + Leucovorin + M3T01 + Oxaliplatin + Pembrolizumab
Age Groups:	senior \| adult
Covered Countries	USA

Additional content available in CKB BOOST